Package 72189-312-03

{"route": ["ORAL"], "spl_id": "2c3cf1d7-38f6-4d25-e063-6294a90aa8cd", "openfda": {"nui": ["N0000175462", "M0015066", "N0000009947"], "unii": ["G70B4ETF4S", "OTT9J7900I"], "rxcui": ["476556"], "spl_set_id": ["d67e2df4-4094-4f5a-e053-2a95a90ae4aa"], "pharm_class_cs": ["Nucleosides [CS]"], "pharm_class_epc": ["Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]"], "pharm_class_moa": ["Nucleoside Reverse Transcriptase Inhibitors [MoA]"], "manufacturer_name": ["DirectRx"]}, "finished": true, "packaging": [{"sample": false, "description": "3 TABLET, FILM COATED in 1 BOTTLE (72189-312-03)", "package_ndc": "72189-312-03", "marketing_start_date": "20220126"}], "brand_name": "EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE", "product_id": "72189-312_2c3cf1d7-38f6-4d25-e063-6294a90aa8cd", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]", "Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]", "Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]", "Nucleoside Reverse Transcriptase Inhibitors [MoA]", "Nucleoside Reverse Transcriptase Inhibitors [MoA]", "Nucleosides [CS]", "Nucleosides [CS]"], "product_ndc": "72189-312", "generic_name": "EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE", "labeler_name": "DirectRx", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE", "active_ingredients": [{"name": "EMTRICITABINE", "strength": "200 mg/1"}, {"name": "TENOFOVIR DISOPROXIL FUMARATE", "strength": "300 mg/1"}], "application_number": "ANDA204131", "marketing_category": "ANDA", "marketing_start_date": "20220126", "listing_expiration_date": "20261231"}